Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. APP.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Basic and Preclinical Sciences.
Date: June 14-16, 2009.
Time: 6 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter Kozel, PhD, Scientific Review Officer, NCCAM, 6707 Democracy Boulevard, Suite 401, Bethesda, MD 20892-5475, 301-496-8004, email@example.com.Start Signature
Dated: May 15, 2009.
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-12192 Filed 5-26-09; 8:45 am]
BILLING CODE 4140-01-P